[Resilience in COVID-19 times: general considerations on the recovery of a 93-year-old patient on haemodialysis treatment].


Journal

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
ISSN: 1724-5990
Titre abrégé: G Ital Nefrol
Pays: Italy
ID NLM: 9426434

Informations de publication

Date de publication:
05 Oct 2020
Historique:
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 21 10 2020
Statut: epublish

Résumé

We report the case of a 93-year-old woman on haemodialysis treatment for more than 30 months and with multiple comorbidities who recovered from a Covid-19 infection without any significant clinical problems. The patient has shown a delay in viral clearance with swab test negativization (confirmed) after 33 days; after testing positive again, she has resulted persistently negative, (confirmed after 49 days). After the first negative swab, IgG and IgM antibodies have been found; these have remained persistently positive after a month. As well as highlighting an unexpected resilience in an extremely fragile context, the analysis of this case draws attention to patients' management and, potentially, to the need to arrange dialysis treatments in isolation for some time after their "laboratory recovery".

Identifiants

pubmed: 33026203
pii: 37-5-2020-7
pii:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0
Platelet Aggregation Inhibitors 0
calcium heparin 37270-89-6
Hydroxychloroquine 4QWG6N8QKH
Heparin 9005-49-6
Calcitriol FXC9231JVH

Types de publication

Case Reports

Langues

ita

Sous-ensembles de citation

IM

Informations de copyright

Copyright by Società Italiana di Nefrologia SIN, Rome, Italy.

Auteurs

Giovanni Mosconi (G)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Alessandra Spazzoli (A)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Paolo Ferdinando Bruno (PF)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Maria Laura Angelini (ML)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Stefania Cristino (S)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Maria Francesca Lifrieri (MF)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Claudio Americo (C)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Marco De Fabritiis (M)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Katia Ambri (K)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Giorgio Dirani (G)

Unità Operativa Microbiologia - Laboratorio Unico Azienda USL della Romagna, Emilia Romagna, Italy.

Simona Semprini (S)

Unità Operativa Microbiologia - Laboratorio Unico Azienda USL della Romagna, Emilia Romagna, Italy.

Vittorio Sambri (V)

Unità Operativa Microbiologia - Laboratorio Unico Azienda USL della Romagna, Emilia Romagna, Italy.

Loretta Zambianchi (L)

Unità Operativa Nefrologia e Dialisi, Forlì-Cesena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH